Clinical controversies: Proton radiation therapy for brain and skull base tumors

Seminars in Radiation Oncology

Volumn 23, Issue 2, 2013, Pages 120-126

  Combs, Stephanie E ^a   Laperriere, Normand ^b   Brada, Michael ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON;

ACOUSTIC NEURINOMA; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHONDROSARCOMA; CHORDOMA; COMPUTER ASSISTED RADIOTHERAPY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; LONG TERM CARE; MENINGIOMA; OPTIC NERVE DISEASE; OVERALL SURVIVAL; PATIENT SAFETY; PHOTON; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; RADIATION DOSE REDUCTION; RADIATION HAZARD; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKULL BASE CHONDROSARCOMA; SKULL BASE CHORDOMA; SKULL BASE TUMOR; SKULL TUMOR; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; ORGANS AT RISK; PHOTONS; PROTON THERAPY; QUALITY OF LIFE; RADIATION ONCOLOGY; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SKULL BASE NEOPLASMS;

EID: 84875254807     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2012.11.011     Document Type: Article

References (51)

1. McAllister B., Archambeau J.O., Nguyen M.C., et al. Proton therapy for pediatric cranial tumors: Preliminary report on treatment and disease-related morbidities. Int J Radiat Oncol Biol Phys 1997, 39:455-460.
2. Hug E.B., Muenter M.W., Archambeau J.O., et al. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 2002, 178:10-17.
3. Fitzek M.M., Thornton A.F., Harsh G., et al. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: Results of an institutional phase I/II trial. Int J Radiat Oncol Biol Phys 2001, 51:131-137.
4. Kuhlthau K.A., Pulsifer M.B., Yeap B.Y., et al. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol 2012, 30:2079-2086.
5. Mizumoto M., Nakayama H., Tokita M., et al. Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve. Strahlenther Onkol 2010, 186:36-39.
6. Mizumoto M., Tsuboi K., Igaki H., et al. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2010, 77:98-105.
7. Milker-Zabel S., Zabel A., Huber P., et al. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. Int J Radiat Oncol Biol Phys 2004, 59:1088-1096.
8. Milker-Zabel S., Debus J., Thilmann C., et al. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 2001, 50:1279-1286.
9. Weber D.C., Momjian S., Pralong F.P., et al. Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma. Radiol Oncol 2011, 6:169.
10. Brada M., Jankowska P. Radiotherapy for pituitary adenomas. Endocrinol Metab Clin North Am 2008, 37:263-275. xi.
11. Minniti G., Traish D., Ashley S., et al. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 2006, 64:542-548.
12. Ronson B.B., Schulte R.W., Han K.P., et al. Fractionated proton beam irradiation of pituitary adenomas. Int J Radiat Oncol Biol Phys 2006, 64:425-434.
13. Petit J.H., Biller B.M., Yock T.I., et al. Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab 2008, 93:393-399.
14. Petit J.H., Biller B.M., Coen J.J., et al. Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract 2007, 13:726-734.
15. Bolsi A., Fogliata A., Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: A treatment planning study. Radiother Oncol 2003, 68:1-14.
16. Louis D.N., Scheithauer B.W., Budka H., et al. World Health Organization classification of tumours. Pathology and Genetics: Tumours of the Nervous System 2000, 176-189. IARC, Lyon. P. Kleihues, W.K. Cavanee (Eds.).
17. Louis D.N., Ohgaki H., Wiestler O.D., et al. WHO classification of tumours of the central nervous system. World Health Organization Classification of Tumours 2007, International Agency for Research on Cancer, Lyon. 4th ed.
18. Palma L., Celli P., Franco C., et al. Long-term prognosis for atypical and malignant meningiomas: A study of 71 surgical cases. J Neurosurg 1997, 86:793-800.
19. Kallio M., Sankila R., Hakulinen T., et al. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 1992, 31:2-12.
20. Salazar O.M. Ensuring local control in meningiomas. Int J Radiat Oncol Biol Phys 1988, 15:501-504.
21. Lusis E., Gutmann D.H. Meningioma: An update. Curr Opin Neurol 2004, 17:687-692.
22. Simon M., Boström J., Koch P., et al. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: Impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 2006, 77:767-773.
23. Engenhart-Cabillic R., Farhoud A., Sure U., et al. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 2006, 182:641-646.
24. Milosevic M.F., Frost P.J., Laperriere N.J., et al. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996, 34:817-822.
25. Hug E.B., DeVries A., Thornton A.F., et al. Management of atypical and malignant meningiomas: Role of high-dose, 3D-conformal radiation therapy. J Neurooncol 2000, 48:151-160.
26. Pasquier D., Bijmolt S., Veninga T., et al. Atypical and malignant meningioma: Outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the rare cancer network. Int J Radiat Oncol Biol Phys 2008, 71:1388-1393.
27. Wenkel E., Thornton A.F., Finkelstein D., et al. Benign meningioma: Partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 2000, 48:1363-1370.
28. Vernimmen F.J., Harris J.K., Wilson J.A., et al. Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2001, 49:99-105.
29. Boskos C., Feuvret L., Noel G., et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 2009, 75:399-406.
30. Halasz L.M., Bussière M.R., Dennis E.R., et al. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys 2011, 81:1428-1435.
31. Combs S.E., Volk S., Schulz-Ertner D., et al. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): Long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys 2005, 63:75-81.
32. Combs S.E., Thilmann C., Debus J., et al. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Int J Radiat Oncol Biol Phys 2006, 64:1341-1347.
33. Combs S.E., Welzel T., Schulz-Ertner D., et al. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 2010, 76:193-200.
34. Bush D.A., McAllister C.J., Loredo L.N., et al. Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery 2002, 50:270-273.
35. Weber D.C., Chan A.W., Bussiere M.R., et al. Proton beam radiosurgery for vestibular schwannoma: Tumor control and cranial nerve toxicity. Neurosurgery 2003, 53:577-586.
36. Catton C., O'Sullivan B., Bell R., et al. Chordoma: Long-term follow-up after radical photon irradiation. Radiother Oncol 1996, 41:67-72.
37. Romero J., Cardenes H., la Torre A., et al. Chordoma: Results of radiation therapy in eighteen patients. Radiother Oncol 1993, 29:27-32.
38. Debus J., Schulz-Ertner D., Schad L., et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 2000, 47:591-596.
39. Gay E., Sekhar L.N., Rubinstein E., et al. Chordomas and chondrosarcomas of the cranial base: Results and follow-up of 60 patients. Neurosurgery 1995, 36:887-896.
40. Austin-Seymour M., Munzenrider J., Goitein M., et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 1989, 70:13-17.
41. Hug E.B., Loredo L.N., Slater J.D., et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999, 91:432-439.
42. Santoni R., Liebsch N., Finkelstein D.M., et al. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys 1998, 41:59-68.
43. Terahara A., Niemierko A., Goitein M., et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999, 45:351-358.
44. Colli B.O., Al-Mefty O. Chordomas of the skull base: Follow-up review and prognostic factors. Neurosurg Focus 2001, 10:E1.
45. Igaki H., Tokuuye K., Okumura T., et al. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 2004, 60:1120-1126.
46. Weber D.C., Rutz H.P., Pedroni E.S., et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: The Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys 2005, 63:401-409.
47. Noël G., Bollet M.A., Calugaru V., et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys 2005, 62:1412-1422.
48. Schulz-Ertner D., Karger C.P., Feuerhake A., et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007, 68:449-457.
49. Ares C., Hug E.B., Lomax A.J., et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: First long-term report. Int J Radiat Oncol Biol Phys 2009, 75:1111-1118.
50. Noël G., Habrand J.L., Jauffret E., et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol 2003, 179:241-248.
51. Rosenberg A.E., Nielsen G.P., Keel S.B., et al. Chondrosarcoma of the base of the skull: A clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 1999, 23:1370-1378.